Upgrade to SI Premium - Free Trial

UBS Reiterates Neutral Rating on Clorox (CLX) as External Challenges Persist

June 12, 2026 9:44 AM
UBS analyst Peter Grom reiterated a Neutral rating and $96.00 price target on Clorox (NYSE: CLX).The analyst commented, "On Thursday ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments